ArQule Message Board - Msg: 2967318

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (122)	12/15/1997 10:28:00 AM
From: SteveG	Read Replies (1) of 399

<...Companies tend to save up major announcements for the Hambrecht and Quist conference. I wouldn't be surprised to see ARQL release some very positive news at this time...> I agree. This is H&Q's Rachel Leheny's #1 pick. A price target of mid to upper 20's goinfg into conference has been suggested. We may also see more preliminary news ahead of the conference: <A> ArQule Gains License for the Synthesis of alpha-Amino Acids from the University of Southern California from biz.yahoo.com Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next